Since the end of April, it hasn’t been all that unusual to see stocks down -10% or more. Since both the Trump administration and Chinese officials have announced agreement on phase one of a trade agreement last week, however, the market is pushing to a new set of all-time highs – something that should give […]
Read MoreTrade Setup Buy Target $17.27 Sell Target $19.13 Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. It offers Accelerate Pheno system, an in vitro diagnostic platform for the identification and antibiotic susceptibility testing of pathogens associated with serious […]
Read MorePlus, tech stocks are soaring, questions remain on the U.S.-China phase one trade agreement, and homebuilder confidence surged to its highest level in 20 years this month.
Read MoreBuy Target – $65.50 or better Sell Target – TradersPro Sell Signal Synaptics Incorporated develops, markets, and sells intuitive human interface solutions for electronic devices and products worldwide. The company offers ClearPad, which enables users to interact directly with the display on mobile smartphones, tablets, and automobiles; ClearView products that provide advanced image processing and […]
Read MoreOne of the big challenges any business, in any industry faces is the ability to remain relevant. There isn’t a single aspect of the economy that isn’t impacted by the progress of science and technology, and that means that what a business is doing today will change. That change could simply affect the way a […]
Read MoreBuy Target $13.97 or better Sell Target – TradersPro Sell Signal Fulgent Genetics, Inc., together with its subsidiaries, provides genetic testing services to physicians with clinically actionable diagnostic information. Its technology platform integrates data comparison and suppression algorithms, adaptive learning software, and genetic diagnostics tools and integrated laboratory processes. The company primarily serves hospitals and […]
Read MoreThis morning, news broke, first from the Chinese, but then shortly afterward confirmed by a Trump tweet, that a Phase One deal had been reached between the two countries. The immediate boon for investors is the fact that because the agreement was reached, tariffs that were set to be imposed in two days, on December […]
Read MorePlus, U.K. Prime Minister Boris Johnson won a landslide victory and promises Brexit by the end of January, the House is expected to vote on two articles of impeachment agains President Trump next week, and Oracle shares are down.
Read MoreThese 2 biotechs could see double digit upside over the next year.
Read MoreMorgan Stanley’s Chief Equity Strategist is bearish on 2020, and the greatest risk he’s identified for the market next year might surprise you.
Read MoreMorgan Stanley says the opportunity for this stock is out of this world.
Read MoreThe long-awaited “phase one” trade deal has finally been signed off on by President Trump, and Jim Cramer says these 21 stocks stand to gain on the deal.
Read MoreOver the last couple of weeks, trade concerns have, not surprisingly, taken center stage in the marketplace all over again. Most other indications – jobs and wage growth, interest rate policy – continue to point to the prospect of a stable, manageable economy for the time being, and even the foreseeable future. That means that […]
Read MorePlus, jobless claims just delivered a surprise, Saudi Aramco hit a $2 trillion valuation, and Credit Suisse says Apple’s iPhone shipments have dropped by double digits in China.
Read MoreAnalysts rate these 7 defensive picks Strong Buys.
Read More